Tomić, D., Skala, K., Kranjčević, L., Pirkić, B., Štifter, S. & Šmit, I. (2018). Evaluation of the Efficacy of Cancer Drugs by Using the Second Largest Eigenvalue of Metabolic Cancer Pathways. Journal of Computer Science & Systems Biology, 11. (3), 240-248. doi: 10.4172/jcsb.1000280
Tomić, Draško, et al. "Evaluation of the Efficacy of Cancer Drugs by Using the Second Largest Eigenvalue of Metabolic Cancer Pathways." Journal of Computer Science & Systems Biology, vol. 11, no. 3, 2018, pp. 240-248. https://doi.org/10.4172/jcsb.1000280
Tomić, Draško, Karolj Skala, Lado Kranjčević, Boris Pirkić, Sanja Štifter and Iva Šmit. "Evaluation of the Efficacy of Cancer Drugs by Using the Second Largest Eigenvalue of Metabolic Cancer Pathways." Journal of Computer Science & Systems Biology 11, no. 3 (2018): 240-248. https://doi.org/10.4172/jcsb.1000280
Tomić, D., et al. (2018) 'Evaluation of the Efficacy of Cancer Drugs by Using the Second Largest Eigenvalue of Metabolic Cancer Pathways', Journal of Computer Science & Systems Biology, 11(3), pp. 240-248. doi: 10.4172/jcsb.1000280
Tomić D, Skala K, Kranjčević L, Pirkić B, Štifter S, Šmit I. Evaluation of the Efficacy of Cancer Drugs by Using the Second Largest Eigenvalue of Metabolic Cancer Pathways. Journal of Computer Science & Systems Biology [Internet]. 2018 [cited 2024 August 28];11(3):240-248. doi: 10.4172/jcsb.1000280
D. Tomić, K. Skala, L. Kranjčević, B. Pirkić, S. Štifter and I. Šmit, "Evaluation of the Efficacy of Cancer Drugs by Using the Second Largest Eigenvalue of Metabolic Cancer Pathways", Journal of Computer Science & Systems Biology, vol. 11, no. 3, pp. 240-248, 2018. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:708181. [Accessed: 28 August 2024]